Code of Federal Regulations (alpha)

CFR /  Title 21  /  Part 814: Premarket Approval Of Medical Devices

Section No. Description
Section 814.1 Purpose
Section 814.2 Definitions
Section 814.3 Confidentiality of data and information in a premarket approval application (PMA) file
Section 814.9 Research conducted outside the United States
Section 814.15 Service of orders
Section 814.17 Product development protocol (PDP)
Section 814.19 Application
Section 814.20 PMA amendments and resubmitted PMAs
Section 814.37 PMA supplements
Section 814.39 Time frames for reviewing a PMA
Section 814.40 Filing a PMA
Section 814.42 Procedures for review of a PMA
Section 814.44 Denial of approval of a PMA
Section 814.45 Withdrawal of approval of a PMA
Section 814.46 Temporary suspension of approval of a PMA
Section 814.47 General
Section 814.80 Postapproval requirements
Section 814.82 Reports
Section 814.84 Purpose and scope
Section 814.100 Designation of HUD status
Section 814.102 Original applications
Section 814.104 HDE amendments and resubmitted HDE's
Section 814.106 Supplemental applications
Section 814.108 New indications for use
Section 814.110 Filing an HDE
Section 814.112 Timeframes for reviewing an HDE
Section 814.114 Procedures for review of an HDE
Section 814.116 Denial of approval or withdrawal of approval of an HDE
Section 814.118 Temporary suspension of approval of an HDE
Section 814.120 Confidentiality of data and information
Section 814.122 Institutional Review Board requirements
Section 814.124 Postapproval requirements and reports
Section 814.126 Scope